UW Health Joins National Research Network Dedicated to Finding Treatments for Food Allergies
Madison, Wisconsin - UW Health is joining the Food Allery Research & Education (FARE) Clinical Network, a food-allergy research collaborative made up of 33 leading research and clinical care facilities across the country. Emory University with Children's Healthcare of Atlanta also joined the network.
FARE is the largest private funder of food-allergy research in the world. Launched in 2015, the FARE Clinical Network seeks to accelerate the development of effective approaches to food-allergy treatment and improve the quality of patient care for this potentially life-threatening disease affecting 32 million Americans, including one in 13 children.
More than 40 percent of children with food allergies have required emergency room care or experienced a severe or life-threatening reaction. And, according to a recent FARE-supported study analyzing state-by-state data, severe food-allergy reactions have climbed dramatically over the last decade, with medical claim lines with food allergy diagnoses increasing 75 percent in Wisconsin since 2009.
"UW Health is always seeking to advance the health of our patients through service and science. Our physicians and researchers pursue this mission with a vision and vigor matched by FARE's commitment to addressing this growing disease," said Anne-Marie Singh, associate professor of pediatrics at the University of Wisconsin School of Medicine and Public Health. "Joining the FARE Clinical Network will allow our specialists to continue to provide excellent care while contributing to breakthroughs in the treatment of food allergies."
Members of the FARE Clinical Network provide high-quality clinical and sub-specialty food-allergy expertise and services and are focused on applying new evidence-based knowledge. They are also a powerful driver of research, serving as sites for clinical trials, the development of best practices for patient care, and in some cases, a national food-allergy patient registry.
"Expanding the FARE Clinical Network is critical for increasing access to cutting-edge research and crucial new therapies for food allergy patients," said Lisa Gable, CEO of FARE. "The results of our study highlight how critical it is for patients that these amazing medical centers have joined our clinical network. We are so pleased to announce our partnership with the dedicated teams at Emory/Children’s and UW Health in Wisconsin, and we look forward to strengthening our research, clinical care and awareness efforts together."
Date Published: 02/15/2019